On March 14, 2016, Nuvectra Corporation completed its spin-off from Greatbatch, Inc. into an independent, publicly-traded neurostimulation medical device company. The company is headquartered in Plano, Texas, with additional locations in Denver, Ann Arbor, and Minneapolis.
Nuvectra currently trades on the NASDAQ Global Market (NASDAQ) under the ticker symbol "NVTR."
Data provided by Nasdaq. Minimum 15 minutes delayed.
September 11, 2017
First Spinal Cord Stimulator Implant Placed in Northern California by Dr. Goldthwaite Brings Pain Relief and Reduces Opioid Use for Local Injured Veteran
PLANO, Texas, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Noel Goldthwaite, MD, senior surgeon and founding member at SpineCare Medical Group, Inc., is the first physician in northern California to implant Nuvectra’s Algovita® Spinal Cord Stimulation System, which successfully treated a local injured veteran’s chronic pain and led to his significant reduction in opioid use. The Nuvectra Algovita SCS System is a powerful and versatile spinal cord stimulation system that includes the smallest patient con
August 30, 2017
Nuvectra to Participate in Morgan Stanley Global Healthcare Conference
PLANO, Texas, Aug. 30, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & CFO, are scheduled to participate at the Morgan Stanley Global Healthcare Conference in New York, NY. Event: Morgan Stanley Global Healthcare Conference Date: Monday, September 11, 2017 The Company will be participating in one-on-one investor m
The Ruth Group
|There are currently no events scheduled.|